FASENRA PEN

Описание товара

About FASENRA PEN

FASENRA PEN is a prescription medicine used for the treatment of severe asthma in patients 12 years and older. It contains the active ingredient BENRALIZUMAB, which is an interleukin-5 receptor alpha subunit inhibitor. FASENRA PEN is designed to provide a convenient and easy-to-use administration of BENRALIZUMAB, helping to reduce the frequency of asthma attacks and improve lung function.

Key Benefits & Uses

• Treatment of severe asthma in patients 12 years and older
• Reduces the frequency of asthma attacks
• Improves lung function and overall quality of life

Active Ingredient & Action

BENRALIZUMAB, the active ingredient in FASENRA PEN, works by binding to the interleukin-5 receptor alpha subunit on eosinophils, a type of white blood cell involved in asthma. This binding causes the depletion of eosinophils, which can contribute to the inflammation and symptoms associated with asthma. By reducing eosinophil counts, BENRALIZUMAB helps to decrease inflammation and improve asthma symptoms.

Important Notes

FASENRA PEN should only be used under the guidance of a healthcare professional. Patients should follow the recommended dosage and administration instructions carefully. It is also important to note that FASENRA PEN is not a rescue medication and should not be used to treat acute asthma attacks. Patients should have a rescue inhaler available at all times.